鄭榮輝，廣州醫(yī)科大學(xué)附屬腫瘤醫(yī)院主任醫(yī)師，博士生導(dǎo)師，博士后合作導(dǎo)師
在廣州醫(yī)科大學(xué)附屬腫瘤醫(yī)院放療科工作19年，目前擔(dān)任放療科副主任（兼教學(xué)主任、放療科二區(qū)負(fù)責(zé)人），頭頸腫瘤放療學(xué)術(shù)帶頭人，廣東省鼻咽癌防治科技教育基地常務(wù)副主任。榮獲嶺南名醫(yī)、廣東省優(yōu)秀科普專(zhuān)家、南方杰出科普醫(yī)生、廣東實(shí)力中青年醫(yī)生、首屆廣州好醫(yī)生等榮譽(yù)稱(chēng)號(hào)，獲市級(jí)人才項(xiàng)目（廣州市優(yōu)秀專(zhuān)家）。主要學(xué)術(shù)任職：廣東省健康科普促進(jìn)會(huì)頭頸腫瘤防治分會(huì)主任委員、中國(guó)健康促進(jìn)基金會(huì)胸部腫瘤放療分會(huì)副主任委員、中國(guó)抗癌協(xié)會(huì)腫瘤熱療分會(huì)委員、中國(guó)健康促進(jìn)基金會(huì)頭頸腫瘤分會(huì)常務(wù)委員、廣州市醫(yī)師協(xié)會(huì)放射腫瘤學(xué)分會(huì)主任委員、廣東省醫(yī)學(xué)會(huì)腫瘤學(xué)分會(huì)鼻咽癌學(xué)組組長(zhǎng)、廣東省精準(zhǔn)醫(yī)學(xué)與應(yīng)用協(xié)會(huì)放射腫瘤分會(huì)副主任委員、廣東省器官醫(yī)學(xué)與技術(shù)協(xié)會(huì)腫瘤精準(zhǔn)治療分會(huì)副主任委員、廣東省醫(yī)學(xué)會(huì)放射腫瘤分會(huì)常務(wù)委員、廣東省醫(yī)師協(xié)會(huì)放射腫瘤分會(huì)常務(wù)委員、廣州市醫(yī)師協(xié)會(huì)常務(wù)理事、《實(shí)用醫(yī)學(xué)雜志》編委/審稿專(zhuān)家。主持（或主要負(fù)責(zé)）各級(jí)科技或教育項(xiàng)目16項(xiàng)，第一/共一或通訊/共同通訊作者發(fā)表論文44篇，獲各級(jí)獎(jiǎng)項(xiàng)/榮譽(yù)共33項(xiàng)。
編寫(xiě)指南或?qū)Ｖ闆r：
2020年《鼻咽癌診療規(guī)范手冊(cè)》（人民衛(wèi)生出版社）編委
2023年中國(guó)抗癌協(xié)會(huì)《腫瘤熱療指南》編委
2024年中國(guó)民族衛(wèi)生協(xié)會(huì)國(guó)家放射外科指南（在編中）副主編
2024年《防癌36計(jì)》（人民衛(wèi)生出版社）主編
聯(lián)系方式:電話15918651199；郵箱[email protected]
研究領(lǐng)域
（1）腫瘤綜合治療免疫微環(huán)境與放射損傷機(jī)制研究；
（2）鼻咽癌為首頭頸腫瘤放射損傷影像/放射劑量與臨床轉(zhuǎn)化研究。
近5年發(fā)表SCI論文：
1.Chen C, Ren A, Yi Q, Cai J, Khan M, Lin Y, Huang Z, Lin J, Zhang J, Liu W, Xu A, Tian Y, Yuan YW*, Zheng RH*. Therapeutic hyperthermia regulates complement C3 activation and suppresses tumor development through HSPA5/NFκB/CD55 pathway in nasopharyngeal carcinoma. Clin Exp Immunol. 2023 Jul 21;213(2):221-234.（2區(qū)，IF 4.6）
2.Wenze.Qiu，Jiali.Jiang，Zejiang.Zhan，Laiji.Huang，Jin.Deng，Jiacai.Ye，Guo.Li，Kai.Liao，Huanhuan.Zhang，Yan.Ding，Yawei.Yuan*，Ronghui.Zheng* .Prognostic impact of pretreatment serum superoxide dismutase activity in patients with locoregionally advanced nasopharyngeal carcinoma.Int J Biol Markers. 2022 Mar;37(1):21-30.（4區(qū)，IF 3.248）
3. Hao-Yun Tao*, Ze-Jiang Zhan*, Wen-Ze Qiu, Kai Liao, Ya-Wei Yuan, Tai-Ze Yuan*, Rong-Hui Zheng*.Clinical value of docetaxel plus cisplatin (TP) induction chemotherapy followed by TP concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma. Journal of Cancer 2021; 12(1): 18-27.（3區(qū)，IF 4.478）
4.Hao-Yun Tao，Ze-Jiang Zhan，Wen-Ze Qiu， Kai Liao， Ya-Wei Yuan*，Rong-Hui Zheng*.Docetaxel and cisplatin induction chemotherapy with or without fluorouracil in locoregionally advanced nasopharyngeal carcinoma: A retrospective propensity score matching analysis. Asia-Pac J Clin Oncol. 2021;1–8.（4區(qū)，IF 1.926）
5.Zhan ZJ, Yao WY, Zhang F, Qiu WZ, Liao K, Feng JH, Tan JY, Liu H, Yuan TZ, Zheng RH*, Yuan YW*. The Optimal Second-Line Systemic Treatment Model for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: A Bayesian Network Meta-Analysis. Front Immunol. 2021 Aug 2;12:719650.（2區(qū)，IF 8.787）
6.Tao HY, Liu H, He F, He CX, Li R, Du KP, Yuan YW*, Zheng RH*. Adjuvant chemotherapy following combined induction chemotherapy and concurrent chemoradiotherapy improves survival in N2-3-positive nasopharyngeal carcinoma patients. J Cancer Res Clin Oncol. 2022 Nov;148(11):2959-2969. （3區(qū)，IF 4.322）
7.Baiyao Wang,Xiaoting Huang,Huiping Liang,Hongli Yang,Zhaoze Guo,Meiling Ai,Jiang Zhang,Muhammad Khan,Yunhong Tian,Quanquan Sun,Zixu Mao,Ronghui Zheng*,Yawei YuanL*. PLK1 inhibition sensitizes breast cancer cells to radiation via suppressing autophagy. Int J Radiat Oncol Biol Phys. 2021 Feb 20;S0360-3016(21)00203-0.（1區(qū)，IF 8.013）
8.Liao K, Tao HY, Zhan ZJ, Qiu WZ, Zheng RH. Retrospective Analysis of Induction Chemotherapy plus Concurrent Chemoradiotherapy under Intensity-Modulated Radiotherapy Mode for Locally Advanced Nasopharyngeal Carcinoma. Oncol Res Treat. 2021;44(11):602-612. （4區(qū)，IF 2.844）
9.Ze-Jiang Zhan*, Hao-Yun Tao*, Wen-Ze Qiu, Zhong-Yuan Liu， Rui-Xin Zhang, Kai Liao, Guo Li, Ya-Wei Yuan1, Tai-Ze Yuan* and Rong-Hui Zheng* .Clinical value of nedaplatin-based chemotherapy combined with radiotherapy for locoregional advanced nasopharyngeal carcinoma: a retrospective, propensity score-matched analysis.J Cancer. 2020 Sep 30;11(23):6782-6789. （3區(qū)，IF 4.478）
10. Rong-Li，Yunhong-Tian，Jian-Zhang，Jie-Lin，Ying-Ying Liang，An-An Xu，Rong-Hui Zheng*，Meng-Zhong Liu*，Ya-Wei Yuan*.Tumor Primary Site and Histology Subtypes Role in Radiotherapeutic Management of Brain Metastases. Front Oncol. 2020 Jul 7;10:781. （2區(qū)，IF 5.738）
11. Yun-Hong Tian，Yun-Ming Tian，Yi-Nuo Tu，Guo-Qian Zhang，Xing Zeng，Jie Lin，Mei-Ling Ai，Zi Xu，Rong-Hui Zheng*，Ya-Wei Yuan*.MicroRNA-124 inhibits stem-like properties and enhances radiosensitivity in nasopharyngeal carcinoma cells via direct repression of expression of JAMA. J Cell Mol Med. 2020 Sep;24(17):9533-9544. （2區(qū)，IF 5.295）
